Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

Conditions:   Good Prognosis Metastatic Gestational Trophoblastic Tumor;   Hydatidiform Mole;   Non-Metastatic Gestational Trophoblastic Tumor;   Uterine Corpus ChoriocarcinomaInterventions:   Biological: Dactinomycin;   Drug: MethotrexateSponsors:   Gynecologic Oncology Group;   Eastern Cooperative Oncology Group;   National Cancer Institute (NCI)Completed - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials